Post-earnings recap
Reported
Tue, Aug 4, 2026
EPS actual
$1.27
EPS est.
$1.22
EPS surprise
+4.53%
1-day move
+3.01%
Henry Schein's earnings report showed a positive surprise on EPS, which likely contributed to the stock's 3.01% increase. However, the lack of revenue data and management commentary leaves some uncertainty about the company's overall performance. Investors may be encouraged by the EPS beat but will be looking for more information in future reports.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.27 | $1.24 | +4.53% |
| Revenue | N/A | $3.4B | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
Henry Schein, Inc. is a leading distributor of health care products and services, primarily serving dental and medical professionals. With a market cap of $10 billion, the company plays a crucial role in the health care supply chain, especially as demand for medical supplies continues to grow amid ongoing health challenges.
Last quarter
In Q1-2026, Henry Schein reported an EPS of $1.32, exceeding expectations by 10.28%. The stock reacted positively, gaining 3.26% the next day.
Management promises and guidance
EPS beat streak
4Q
EPS beat rate
75%
Avg EPS surprise
+3.58%
Avg 1-day reaction
+1.01%
Analysts expect Henry Schein to report solid earnings this quarter, driven by strong demand in the health care sector. The consensus EPS estimate is $1.24, with revenue projected at $3.4 billion.
Bull case
If the company beats earnings expectations, it could signal strong operational efficiency and robust demand, potentially driving the stock higher.
Bear case
Conversely, if earnings fall short, it may raise concerns about market conditions or operational challenges, leading to a negative stock reaction.
Key metrics to watch
EPS
$1.24Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.
Revenue
$3.4BTotal revenue reflects the company's sales performance and market demand for its products and services.
The print will turn on these.
Q1
Will EPS exceed the consensus estimate of $1.24?
A beat on EPS would reinforce investor confidence in the company's growth trajectory and operational efficiency.
Q2
What are the revenue growth expectations in key segments?
Understanding revenue performance in critical areas will provide insight into market demand and the company's competitive positioning.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±12.7%
Why consensus could be wrong
The Street may be underestimating the potential for higher-than-expected demand in the health care sector, particularly in dental supplies.
Supporting evidence
Recent trends show increased spending in health care, which could boost revenue beyond consensus estimates.
The company's historical performance suggests a strong ability to exceed earnings expectations.
Options pricing indicates a significant move, suggesting that traders anticipate volatility that could favor a positive outcome.
Key risk
If revenue growth in key segments comes in below expectations, it could challenge the overall bullish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance is critical as it will indicate whether the company can maintain its growth momentum amid market challenges.
Bull confirmed if
Achieving an EPS above $1.30 would confirm strong operational performance and demand.
Bear confirmed if
An EPS below $1.17 would raise concerns about the company's growth and market conditions.
What the market is pricing for the move.
Implied Move
±16.0%
Historical Avg
±4.6%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±16.0% while HSIC has averaged ±4.6% over the last 8 prints — setup is pricing rich.
ATM IV
0.3%
30d HV
27.4%
Smart-money positioning from the most recent 13F filings.
Institutional
112.27%
of float
Insider
0.83%
of float
Holders
785
institutions
Top Holders· as of Jun 2026
Kohlberg Kravis Roberts & Co. L.P.
15,652,032 sh · $1.3B
14.04%
Flat
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Henry Schein beats expectations, history suggests a potential stock increase of around +0.63%, confirming strong demand and operational efficiency.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further guidance.
Miss
A miss could lead to a decline of around -7.41%, reflecting concerns about the company's ability to navigate market challenges.
The lines on the call that would change the story.
FMR, LLC
7,553,901 sh · $632.0M
6.78%
32.0%
Blackrock Inc.
7,024,663 sh · $587.7M
6.30%
0.0%
Artisan Partners Limited Partnership
6,467,467 sh · $541.1M
5.80%
-1.6%
Vanguard Capital Management LLC
6,346,669 sh · $531.0M
5.69%
-1.2%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.